Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Closes on Controlling Stake in Emory Genetics Laboratory

NEW YORK (GenomeWeb) – French genomic services firm Eurofins today announced it has successfully acquired a 75 percent stake in the Emory Genetics Laboratory.

The new company will be called EGL Genetic Diagnostics, and will operate as a joint venture of Eurofins and Emory University.

Eurofins said in a statement that the laboratory serves over 400 institutional clients across the US and expects to generate more than $15 million in revenues for the Fiscal Year 2015.

Eurofins announced in June that it would purchase the controlling stake in the lab. The firm also acquired Diatherix Laboratories that month.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.